Zhejiang Wild Wind pharmaceutical Co., Ltd. is a state’s hi-tech enterprise specializes in manufacturing pharmaceuticals and intermediates. The APIs includes: Methyldopa, Carbidopa, Levodopa,Caspofungin Acetate, Silrolimus (Rapamycin) etc.。The company is operated according to GMP, ISO9001 quality system and ISO14001 environmental system.
We obtained Methyldopa and Carbidopa GMP certificate from SFDA successfully, and got CEP certificates for Methyldopa, Carbidopa and Levodopa from EDQM.
Warmly welcomes all clients from home and abroad to come for economic and technical cooperation.
more >
Year of Establishment:
1993
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
100-500
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Reputation
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: